AKR1B1 and diabetic neuropathy: The positive effect of inhibiting aldose reductase on diabetic neuropathy includes enhancing sural motor and sensory nerve conduction velocities, improving wrist and ankle F-wave latency together with and alleviating neuropathic pain [143], which have been observed in diabetic mice [143] and in diabetic patients [144].